Cargando…

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies

OBJECTIVE: Lewy body (LB) synucleinopathies such as Parkinson’s disease (PD) entail profound cardiac norepinephrine deficiency. The status of sympathetic noradrenergic innervation at other extracranial sites has been unclear. Although in vivo neuroimaging studies have indicated a cardioselective nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamotte, Guillaume, Holmes, Courtney, Sullivan, Patricia, Lenka, Abhishek, Goldstein, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732242/ https://www.ncbi.nlm.nih.gov/pubmed/33216462 http://dx.doi.org/10.1002/acn3.51243

Ejemplares similares

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
por: Vlachopoulou, Dimitra, et al.
Publicado: (2023)

Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease
por: Serrano, Geidy E, et al.
Publicado: (2020)

Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases
por: Goldstein, David S., et al.
Publicado: (2022)

Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon
por: Song, Sheng, et al.
Publicado: (2023)

Neuropathological studies of serotonergic and noradrenergic systems in Lewy body disease patients with delusion or depression
por: Mizutani, Masashi, et al.
Publicado: (2022)

An evaluation of the effects of nonselective and cardioselective β-blockers on wound healing in Sprague Dawley rats
por: Raut, Sanket B., et al.
Publicado: (2012)

Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
por: Rossi, Marcello, et al.
Publicado: (2020)

Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
por: Crews, Leslie, et al.
Publicado: (2010)

Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations
por: de Boni, Laura, et al.
Publicado: (2022)

Correction to: Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
por: Rossi, Marcello, et al.
Publicado: (2020)

The safety of cardioselective β(1)-blockers in asthma: literature review and search of global pharmacovigilance safety reports
por: Bennett, Miriam, et al.
Publicado: (2021)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy – Implications for Excitotoxicity
por: Price, Diana L., et al.
Publicado: (2010)

Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction
por: Li, Yi, et al.
Publicado: (2018)

Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
por: Lamotte, Guillaume, et al.
Publicado: (2015)

Early microglial activation and peripheral inflammation in dementia with Lewy bodies
por: Surendranathan, Ajenthan, et al.
Publicado: (2018)

Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study
por: Amin, Jay, et al.
Publicado: (2020)

Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
por: King, Eleanor, et al.
Publicado: (2018)

RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy
por: Han, Jung-Youn, et al.
Publicado: (2020)

Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure
por: Lenka, Abhishek, et al.
Publicado: (2023)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
por: Foulds, P.G., et al.
Publicado: (2012)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Jellinger, Kurt A.
Publicado: (2022)

Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies
por: Lamotte, Guillaume, et al.
Publicado: (2022)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
por: Yang, Jing, et al.
Publicado: (2021)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
por: Just, Mie Kristine, et al.
Publicado: (2022)

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Menšíková, Kateřina, et al.
Publicado: (2022)

ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
por: Gao, Fei, et al.
Publicado: (2022)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Lewy body constipation
por: Sakakibara, Ryuji, et al.
Publicado: (2019)

Mechanisms of Neuronal Death in Synucleinopathy
por: Takeda, Atsushi, et al.
Publicado: (2006)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

The Pharmacology of Visual Hallucinations in Synucleinopathies
por: Russo, Mirella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_adl824nivclltushgeq8vb88gj